Intelligence · Clinical Pipeline

Approved programs Pipeline Programs

ClinicalTrials.gov programs marked approved or launched in registry data.

Programs
1,839

Quick answer

NovaPharmaNews tracks 1,839 approved programs pharmaceutical pipeline programs from ClinicalTrials.gov. ClinicalTrials.gov programs marked approved or launched in registry data.

Top sponsors

Page 11 of 39

  1. Drawtex dressing

    United Therapeutics Europe Ltd

    Pilonidal Disease

    approved other active

    1 trial
  2. Dronabinol

    BRIGHT MINDS BIOSCIENCES INC.

    Pregnancy Related

    approved small molecule completed

    1 trial
  3. Drug: Ixazomib Drug:pomalidomide Drug:dexamethasone

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Multiple Myeloma

    approved small molecule active

    1 trial
  4. Drug: cimetidine

    BRIGHT MINDS BIOSCIENCES INC.

    Healthy

    approved small molecule completed

    1 trial
  5. Dual chamber pacemeker

    Rhythm Pharmaceuticals Netherlands B.V.

    Syncope

    approved other completed

    1 trial
  6. Dupilumab

    Regeneron UK Limited

    Allergic Contact Dermatitis

    approved small molecule active

    1 trial
  7. Dupilumab

    Regeneron UK Limited

    Atopic Dermatitis

    approved small molecule active

    16 trials
  8. Dupilumab

    Regeneron UK Limited

    Dermatitis, Atopic

    approved small molecule active

    5 trials
  9. Dupilumab

    Regeneron UK Limited

    Eosinophilic Esophagitis

    approved small molecule active

    4 trials
  10. Dupilumab

    Sanofi Pasteur

    Asthma

    approved small molecule active

    2 trials
  11. Dupilumab

    Regeneron UK Limited

    Atopic Dermatitis (AD)

    approved small molecule terminated

    2 trials
  12. Dupilumab

    Regeneron UK Limited

    Asthma

    approved small molecule active

    13 trials
  13. Dupilumab

    Regeneron UK Limited

    Moderate-to-Severe Atopic Dermatitis

    approved small molecule completed

    2 trials
  14. Dupilumab

    Regeneron UK Limited

    Keloid

    approved small molecule completed

    2 trials
  15. Dupilumab

    Regeneron UK Limited

    Chronic Rhinosinusitis With Nasal Polyps

    approved small molecule completed

    1 trial
  16. Dupilumab

    Regeneron UK Limited

    Eczema

    approved small molecule active

    1 trial
  17. Dupilumab

    Regeneron UK Limited

    Eosinophilic Oesophagitis

    approved small molecule active

    1 trial
  18. Dupilumab

    Regeneron UK Limited

    Chronic Obstructive Pulmonary Disease

    approved small molecule active

    1 trial
  19. Dupilumab

    Regeneron UK Limited

    Dermal Hypersensitivity Reaction

    approved small molecule completed

    1 trial
  20. Dupilumab 300 MG/2 ML Subcutaneous Solution [DUPIXENT]

    Regeneron UK Limited

    Eosinophilic Esophagitis (EoE)

    approved small molecule active

    1 trial
  21. Dupilumab Injectable Product

    Regeneron UK Limited

    Asthma

    approved small molecule active

    1 trial
  22. Dupilumab Only Product

    Regeneron UK Limited

    Atopic Dermatitis

    approved small molecule active

    1 trial
  23. Dupilumab Prefilled Syringe

    Regeneron UK Limited

    Nasal Polyps

    approved small molecule active

    1 trial
  24. Dupilumab SAR231893

    Regeneron UK Limited

    Chronic Rhinosinusitis With Nasal Polyps

    approved small molecule completed

    1 trial
  25. Dupilumab SAR231893

    Regeneron UK Limited

    Atopic Dermatitis

    approved small molecule completed

    1 trial
  26. Dupilumab SAR231893

    Regeneron UK Limited

    Dermatitis Atopic

    approved small molecule completed

    2 trials
  27. Dupilumab, dupilumab placebo, solution for injection in pre-filled syringe

    Sanofi-aventis Healthcare Pty Ltd

    Asthma

    approved small molecule active

    1 trial
  28. Dupilumab, matched placebo for test product, Ventolin Evohaler 100 micrograms

    Sanofi-aventis Healthcare Pty Ltd

    Respiratory tract diseases

    approved small molecule active

    1 trial
  29. Dupixent

    Regeneron UK Limited

    Atopic Dermatitis

    approved small molecule active

    1 trial
  30. Duragesic reference fentanyl TDS

    BRIGHT MINDS BIOSCIENCES INC.

    Peer Review, Research

    approved small molecule completed

    1 trial
  31. Durvalumab

    AstraZeneca

    Solid Tumor

    approved small molecule completed

    1 trial
  32. Dutasteride plus tamsulosin

    GlaxoSmithKline

    Prostatic Hyperplasia

    approved small molecule completed

    1 trial
  33. Dynepo

    Takeda

    Anemia

    approved small molecule terminated

    1 trial
  34. Dysport 300 E, poeder voor oplossing voor injectie

    Disc Medicine

    Dystonic tremor syndrome

    approved small molecule active

    1 trial
  35. EFFIMIA 0,250 mg/0,035mg, Compresse

    Italfarmaco S.p.A.

    Female contraception.

    approved small molecule active

    1 trial
  36. ELAPRASE

    Takeda

    Mucopolysaccharidosis (MPS)

    approved small molecule terminated

    1 trial
  37. ELEVIDYS

    Sarepta Therapeutics

    Duchenne Muscular Dystrophy

    approved small molecule active

    1 trial
  38. ENDORET-PRGF

    The George Institute

    pterygium

    approved small molecule active

    1 trial
  39. ENZALUTAMIDE, DOCETAXEL, ABIRATERONE

    Fondazione Telethon ETS

    metastatic castration resistant prostate cancer without mutations of BRCA1/2 genes or unknown

    approved small molecule active

    1 trial
  40. EPIAO®

    Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    Renal Anaemia

    approved small molecule terminated

    1 trial
  41. ESOMEPRAZOLE, ESOMEPRAZOLE

    Fondazione Telethon ETS

    obesity

    approved small molecule active

    1 trial
  42. ESTECLIN 300 MG CAPSULE RIGIDE

    Zafatek

    COPD

    approved small molecule active

    1 trial
  43. ESTRIOL , ESTRADIOL HEMIHYDRATE, PROMESTRIENE, PROGESTERONE, ESTRADIOL VALERATE

    The George Institute

    Cervical cancer

    approved small molecule active

    1 trial
  44. ETHINYL ESTRADIOL AND LEVOGESTREL

    United Therapeutics Europe Ltd

    HIV/AIDS

    approved small molecule completed

    1 trial
  45. ETN Alone

    Universal Integrated

    Rheumatoid Arthritis

    approved small molecule completed

    1 trial
  46. EUS-guided pancreatic pseudocyst drainage

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Pancreatic Pseudocyst

    approved other active

    1 trial
  47. EV71 Vaccine

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Hand, Foot and Mouth Disease

    approved mab active

    1 trial
  48. EV71 Vaccine

    Sinovac Research and Development Co.,

    EV71 Vaccine

    approved mab completed

    1 trial

Frequently asked questions

How many Approved programs pipeline programs are in the directory?

1,839 published programs match this development stage in our ClinicalTrials.gov index.

What defines this pipeline stage?

Phase and status reflect ClinicalTrials.gov registry fields at last sync. See our clinical trial phases reference for methodology.

Data attribution: Data sources · All pipeline programs